ADC Therapeutics develops cancer treatments, led by ZYNLONTA for certain lymphomas, and is based in Epalinges, Switzerland. It last closed at $1.28 on Nov 20, down 1.54% on the day. The next earnings report for ADCT is expected around Tue, Mar 9, 2027. For the quarter ended Sep 2026, ADCT reported EPS of -$0.16 on revenue of $21.7M, with revenue up 32.2% from a year ago. Over its last 8 reports the stock moved an average of 12.6% the session after earnings. Over the last 12 months ADCT insiders bought $0 of stock on the open market and sold $19.6M, according to SEC Form 4 filings.
AI Auto Pilots
Is ADCT in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold ADCT.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on ADCTStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
ADCT · as of the Nov 20 close · updated each morning
Downtrend
The stock is 17% below its 20 day and 9% below its 50 day average. It is 81% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 42). The nearest support is the Pivot S1 at $1.24, and the nearest resistance the Pivot at $1.30.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityHigh, 12.1%/day
Key levels
$4.9852 week high+289.1%
$2.31200 day average+80.5%
$1.4920 day average+16.4%
$1.4050 day average+9.4%
$1.34Pivot R1+4.7%
$1.32Swing high (Sep 23)+3.1%
$1.30Pivot+1.6%
$1.28100 day average+0.0%
$1.28Last close
$1.24Pivot S1−3.1%
$1.24Swing low (Nov 16)−3.1%
$0.7852 week low−39.1%
Indicators
RSI (14)
42.44
Middle of its range
Neutral
MACD
-0.04
Below its signal line
Bearish
Stochastic
12.3
Near the bottom of its range
Oversold
ADX (14)
18.3
No clear trend
Williams %R
-93.6
Oversold below −80, overbought above −20
Oversold
CCI (20)
-125.5
Oversold below −100, overbought above 100
Oversold
Rate of change
−19.0%
Change over 10 sessions
Bearish
ATR (14)
$0.16
Typical daily range, 12.1% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Below
Downtrend
Short trendBearish
Long trendBearish
MomentumNeutral
StretchNormal
VolatilityHigh, 28.4%/day
Key levels
$4.9852 week high+289.1%
$2.31200 day average+80.5%
$1.4920 day average+16.4%
$1.4050 day average+9.4%
$1.34Pivot R1+4.7%
$1.32Swing high (Sep 23)+3.1%
$1.30Pivot+1.6%
$1.28100 day average+0.0%
$1.28Last close
$1.24Pivot S1−3.1%
$1.24Swing low (Nov 16)−3.1%
$0.7852 week low−39.1%
Indicators
RSI (14)
42.11
Middle of its range
Neutral
MACD
-0.26
Above its signal line
Bullish
Stochastic
49.3
Middle of its range
Neutral
ADX (14)
19.2
No clear trend
Williams %R
-64.1
Oversold below −80, overbought above −20
Neutral
CCI (20)
12.0
Oversold below −100, overbought above 100
Neutral
Rate of change
+19.6%
Change over 10 sessions
Bullish
ATR (14)
$0.36
Typical daily range, 28.4% of price
MA 10Below
MA 20Above
MA 50Below
MA 100Below
MA 200Below
What happened before, for ADCT
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how ADCT did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow ADCT usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for ADCTHow many large options trades hit ADCT, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in ADCT in the last 90 days.
From SEC Form 4 filings by ADCT's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ADCT is in one of them and how their past ADCT trades turned out.
ADC Therapeutics is a biopharmaceutical company based in Epalinges, Switzerland. It develops cancer treatments built on antibody drug conjugates, which link an antibody that targets cancer cells to a cell-killing payload. Its main product is ZYNLONTA, used for a type of lymphoma that has returned or stopped responding to earlier treatment, and partner Sobi handles much of its commercialization. Its customers include patients, the doctors who treat them, and the insurers and government programs that pay for care.